Oxymap

About:

Oxymap provides imaging products and services for eye-care professionals and clinical researchers.

Website: http://www.oxymap.com

Top Investors: EASME - EU Executive Agency for SMEs, Technology Development Fund

Description:

Oxymap is an Icelandic company whose flagship product is the Oxymap T1 – a solution for non-invasive ocular measurements. The company produces novel imaging products and services targeted towards eye-care professionals and clinical researchers to further the understanding of common eye diseases. A team of researchers established Oxymap in Reykjavik in 2002. Their efforts lead to the creation of the Oxymap T1 add-on for a fundus camera, which allows for non-invasive retinal oxygen saturation and vessel-width measurements. The device and accompanying software provide user-friendly access to metabolic and structural information with a single image. Customers at many international institutions are currently relying on the Oxymap T1 for their investigations. The Oxymap development team places a high value on customer feedback as it continually improves the device and software. The bulk of product assembly is carried out by specialised contractors and the final validation performed in-house. Installation, training and customer support for the Oxymap T1 are carried out by experienced employees. An ISO 13485-based quality management process guides the constant improvement of the device, software and customer experience.

Total Funding Amount:

$883000

Headquarters Location:

Reykjavík, Gullbringusysla, Iceland

Founded Date:

2002-01-01

Contact Email:

info(AT)oxymap.com

Founders:

Bryndis Thordardottir, Einar Stefansson

Number of Employees:

1-10

Last Funding Date:

2016-03-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai